Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17552941rdf:typepubmed:Citationlld:pubmed
pubmed-article:17552941lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:17552941lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:17552941lifeskim:mentionsumls-concept:C0010278lld:lifeskim
pubmed-article:17552941lifeskim:mentionsumls-concept:C0034320lld:lifeskim
pubmed-article:17552941lifeskim:mentionsumls-concept:C1314792lld:lifeskim
pubmed-article:17552941lifeskim:mentionsumls-concept:C1521991lld:lifeskim
pubmed-article:17552941lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:17552941lifeskim:mentionsumls-concept:C1414407lld:lifeskim
pubmed-article:17552941lifeskim:mentionsumls-concept:C1418599lld:lifeskim
pubmed-article:17552941lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:17552941lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:17552941pubmed:issue2lld:pubmed
pubmed-article:17552941pubmed:dateCreated2007-6-7lld:pubmed
pubmed-article:17552941pubmed:abstractTextFibroblast growth factor/fibroblast growth factor receptor (FGF/FGFR) signaling is associated with the aberrant mineralization phenotype of the craniosynostosis syndromes. One critical aspect of mineralization involves the elaboration and transport of pyrophosphate into the extracellular matrix with subsequent enzymatic hydrolysis into phosphate. We have previously shown that FGF2 up-regulates expression of the pyrophosphate generating enzyme, PC-1, and the pyrophosphate channel, ANK, while down-regulating expression of the pyrophosphate hydrolyzing enzyme, tissue non-specific alkaline phosphatase in pre-osteoblastic, MC3T3E1(C4) cells. These results suggest that FGF/FGFR signaling may affect mineralization via changes in the elaboration and metabolism of pyrophosphate.lld:pubmed
pubmed-article:17552941pubmed:languageenglld:pubmed
pubmed-article:17552941pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17552941pubmed:citationSubsetDlld:pubmed
pubmed-article:17552941pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17552941pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17552941pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17552941pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17552941pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17552941pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17552941pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17552941pubmed:statusMEDLINElld:pubmed
pubmed-article:17552941pubmed:monthMaylld:pubmed
pubmed-article:17552941pubmed:issn1601-6335lld:pubmed
pubmed-article:17552941pubmed:authorpubmed-author:HatchNan ENElld:pubmed
pubmed-article:17552941pubmed:issnTypePrintlld:pubmed
pubmed-article:17552941pubmed:volume10lld:pubmed
pubmed-article:17552941pubmed:ownerNLMlld:pubmed
pubmed-article:17552941pubmed:authorsCompleteYlld:pubmed
pubmed-article:17552941pubmed:pagination53-8lld:pubmed
pubmed-article:17552941pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:17552941pubmed:meshHeadingpubmed-meshheading:17552941...lld:pubmed
pubmed-article:17552941pubmed:meshHeadingpubmed-meshheading:17552941...lld:pubmed
pubmed-article:17552941pubmed:meshHeadingpubmed-meshheading:17552941...lld:pubmed
pubmed-article:17552941pubmed:meshHeadingpubmed-meshheading:17552941...lld:pubmed
pubmed-article:17552941pubmed:meshHeadingpubmed-meshheading:17552941...lld:pubmed
pubmed-article:17552941pubmed:meshHeadingpubmed-meshheading:17552941...lld:pubmed
pubmed-article:17552941pubmed:meshHeadingpubmed-meshheading:17552941...lld:pubmed
pubmed-article:17552941pubmed:meshHeadingpubmed-meshheading:17552941...lld:pubmed
pubmed-article:17552941pubmed:meshHeadingpubmed-meshheading:17552941...lld:pubmed
pubmed-article:17552941pubmed:meshHeadingpubmed-meshheading:17552941...lld:pubmed
pubmed-article:17552941pubmed:meshHeadingpubmed-meshheading:17552941...lld:pubmed
pubmed-article:17552941pubmed:meshHeadingpubmed-meshheading:17552941...lld:pubmed
pubmed-article:17552941pubmed:meshHeadingpubmed-meshheading:17552941...lld:pubmed
pubmed-article:17552941pubmed:meshHeadingpubmed-meshheading:17552941...lld:pubmed
pubmed-article:17552941pubmed:meshHeadingpubmed-meshheading:17552941...lld:pubmed
pubmed-article:17552941pubmed:meshHeadingpubmed-meshheading:17552941...lld:pubmed
pubmed-article:17552941pubmed:meshHeadingpubmed-meshheading:17552941...lld:pubmed
pubmed-article:17552941pubmed:year2007lld:pubmed
pubmed-article:17552941pubmed:articleTitlePotential role of PC-1 expression and pyrophosphate elaboration in the molecular etiology of the FGFR-associated craniosynostosis syndromes.lld:pubmed
pubmed-article:17552941pubmed:affiliationDepartment of Orthodontics and Pediatric Dentistry, School of Dentistry, University of Michigan, Ann Arbor, MI 48109, USA. nhatch@umich.edulld:pubmed
pubmed-article:17552941pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:18605entrezgene:pubmedpubmed-article:17552941lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17552941lld:entrezgene